Bill Text: TX HB1164 | 2021-2022 | 87th Legislature | Introduced
NOTE: There are more recent revisions of this legislation. Read Latest Draft
Bill Title: Relating to patient safety practices regarding placenta accreta spectrum disorder.
Spectrum: Slight Partisan Bill (Democrat 7-3)
Status: (Passed) 2021-06-15 - Effective on 9/1/21 [HB1164 Detail]
Download: Texas-2021-HB1164-Introduced.html
Bill Title: Relating to patient safety practices regarding placenta accreta spectrum disorder.
Spectrum: Slight Partisan Bill (Democrat 7-3)
Status: (Passed) 2021-06-15 - Effective on 9/1/21 [HB1164 Detail]
Download: Texas-2021-HB1164-Introduced.html
87R5114 SRA-D | ||
By: Oliverson | H.B. No. 1164 |
|
||
|
||
relating to the designation of centers of excellence for the | ||
management and treatment of placenta accreta spectrum disorder. | ||
BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS: | ||
SECTION 1. Chapter 32, Health and Safety Code, is amended by | ||
adding Subchapter G to read as follows: | ||
SUBCHAPTER G. CENTERS OF EXCELLENCE FOR MANAGEMENT AND TREATMENT | ||
OF PLACENTA ACCRETA SPECTRUM DISORDER | ||
Sec. 32.201. DEFINITION. In this subchapter, "placenta | ||
accreta spectrum disorder" includes placenta accreta, placenta | ||
increta, and placenta percreta. | ||
Sec. 32.202. DESIGNATION OF CENTERS OF EXCELLENCE. (a) The | ||
department, in consultation with the Texas Maternal Mortality and | ||
Morbidity Review Committee established under Chapter 34, shall | ||
designate as centers of excellence for the management and treatment | ||
of placenta accreta spectrum disorder one or more health care | ||
entities or programs in this state, including any institution or | ||
community hospital with the appropriate resources and personnel, as | ||
determined by the department and the review committee. | ||
(b) The executive commissioner, in consultation with the | ||
department and the Texas Maternal Mortality and Morbidity Review | ||
Committee, shall adopt rules necessary for a health care entity or | ||
program in this state to be designated as a center of excellence for | ||
management and treatment of placenta accreta spectrum disorder. | ||
Sec. 32.203. SUBCOMMITTEE. (a) The department, in | ||
consultation with the Texas Maternal Mortality and Morbidity Review | ||
Committee, shall appoint a subcommittee of the review committee to | ||
advise the executive commissioner on the adoption of rules under | ||
Section 32.202. As part of the subcommittee's duties under this | ||
subsection, the subcommittee specifically shall advise the | ||
executive commissioner on the criteria necessary for a health care | ||
entity or program in this state to be awarded a designation under | ||
this subchapter. | ||
(b) The subcommittee must consist of individuals with | ||
expertise in the management and treatment of placenta accreta | ||
spectrum disorder. A majority of the members of the subcommittee | ||
must practice in those areas in a health profession in this state. | ||
The subcommittee may include national and international experts. | ||
Sec. 32.204. PRIORITY CONSIDERATIONS FOR CENTER | ||
DESIGNATIONS. The rules adopted under Section 32.202 must | ||
prioritize awarding a designation under this subchapter to a health | ||
care entity or program that: | ||
(1) offers specialized management services for | ||
placenta accreta spectrum disorder through a multi-specialty | ||
clinical program and an associated hospital that provides advanced | ||
neonatal and maternal care in accordance with the hospital's level | ||
of care designation assigned under Section 241.182; | ||
(2) demonstrates a significant commitment to research | ||
in and advancing the field of care for placenta accreta spectrum | ||
disorder; | ||
(3) fosters telemedicine, referral, and transport | ||
relationships with rural hospitals in this state; and | ||
(4) integrates an advanced placenta accreta spectrum | ||
disorder management program with a program that provides | ||
appropriate long-term monitoring and follow-up care for patients. | ||
Sec. 32.205. REQUIREMENTS FOR CENTER DESIGNATION. The | ||
rules adopted under Section 32.202 must ensure that a health care | ||
entity or program in this state that receives a center of excellence | ||
designation under this subchapter: | ||
(1) provides or is affiliated with a hospital that | ||
provides advanced neonatal and maternal care in accordance with the | ||
hospital's level of care designation assigned under Section | ||
241.182; | ||
(2) establishes minimum criteria for medical, | ||
nursing, ancillary, and support staff, in addition to any other | ||
criteria required under Section 32.202; | ||
(3) measures short-term and long-term patient | ||
diagnostic and therapeutic outcomes; and | ||
(4) submits to the department annual reports | ||
containing aggregate data on short-term and long-term diagnostic | ||
and therapeutic outcomes as requested or required by the department | ||
and makes those reports available to the public on the entity's or | ||
program's Internet website. | ||
SECTION 2. (a) Not later than December 1, 2021, the | ||
Department of State Health Services, in consultation with the Texas | ||
Maternal Mortality and Morbidity Review Committee established | ||
under Chapter 34, Health and Safety Code, shall appoint members to | ||
the subcommittee as required by Section 32.203, Health and Safety | ||
Code, as added by this Act. | ||
(b) Not later than September 1, 2022, the executive | ||
commissioner of the Health and Human Services Commission shall | ||
adopt rules as required by Section 32.202, Health and Safety Code, | ||
as added by this Act. | ||
(c) Not later than September 1, 2022, the Department of | ||
State Health Services shall begin awarding designations of centers | ||
of excellence as required by Subchapter G, Chapter 32, Health and | ||
Safety Code, as added by this Act. | ||
SECTION 3. This Act takes effect September 1, 2021. |